Cabinet of Ministers Regulations No. 230 in Riga, 19 may 2015 (pr. No 25 14) amendments to the Cabinet of Ministers of 5 January 1999, regulations No 7 "infectious disease registration order" Issued in accordance with the epidemiological safety law of article 10 and article 14, paragraph 4 of the first paragraph to make the Cabinet of Ministers of 5 January 1999, regulations No 7 "order of registration of infectious diseases" (Latvian journal, 1999, 5./6. No; 2002, 97. nr.; 2003, 111.; 2004, nr. 66. No; 2006, 2007 57. no; 108., no; 2008.100 no; 2009, no. 145; 78. in 2012, no; 2013, 17, nr. 149.) the following amendments: 1. Replace the words "in the text of the provisions of the microbiology laboratory" (fold) with the word "laboratory" (fold). 2. Express 7.2 point as follows: "7.2 Before reporting for disease prevention and control center or the relevant regional Department for medical treatment person's epidemiologists, inform the person on whom it is reported, indicating the purpose of reporting and acknowledging the urgent notification form information provided will only be used for the epidemiological surveillance and pretepidēmij activities. If the person on whom it is reported, is a minor or with a judgment of the Court of Justice in its legal capacity is restricted, shall inform the person's legal representative. " 3. Replace the introductory text of paragraph 9.1 "LVS EN ISO 15189:2008 L" medical laboratory "with the text" LVS EN ISO 15189:13 L "medical laboratory. Quality and competency requirements (ISO 15189:2012). 4. Replace the words in subparagraph 1 9.1 "and Corynebacterium ulcerans" with the words "Corynebacterium ulcerans and Corynebacterium pseudotuberculos". 5. Make 3. section 9.3 the following wording: "9.3 3. Hepatitis C virus antibodies, if laboratory studies hepatitis C diagnoses made for approval of State budget resources." 6. Replace the introductory part of paragraph 10, the words "or approval of other laboratory" with the words "or tipēšan". 7. in paragraph 10.2 replace the words and figures "3. paragraph 17 of the annex to" with the words and figures "3. paragraph 17 of section I". 8. Express 10.5 point as follows: "the 10.5 head of laboratory or his authorised person each quarter to the first quarter of the fifth day of the month submit to the Center for disease prevention and control in a report on primary isolation of s. aureus, s. pneumoniae, e. coli, k. pneumoniae, p. aeruginos, e. faecium/Acinetobacter spp.,/Acinetobacter faecal baumanni micro-organisms by filling out the relevant trigger this provision form shown in annex 4." 9. Delete the 12.1 point. 10. To supplement the provisions of the following paragraph 16: "16. This provision of the requirements mentioned in paragraph 10.5 to report primary/Acinetobacter Acinetobacter baumanni isolated spp. organisms come into force July 1, 2015." 11. Amend Annex 1, 3, 14, 15, 20, 26 and 28. 12. Put 2 and 3 of the annex by the following: "2. the annex to Cabinet of Ministers of 5 January 1999, regulations No 7 infectious diseases No registerable. p. k. Register of infectious diseases in Group 1. Acute flaccid paralysis in children under 15 years of age 2. 2. acute viral hepatitis 2. 3. Bake 1. 4. Botulism 2. 5. Brucellosis 2. 6. Human immunodeficiency virus (HIV) infection and AIDS 3. 7. other newly emerged a dangerous infectious disease * 1. dengue fever 3.8 * 9. Diphtheria and diphtheria agents carrying 2. 10. Yellow fever 1. 11.3 * 12 echinococcosis. Mumps 2. 13. the lice Epidemic typhus and Brill's disease 1. 14. Tick-borne encephalitis 2. 15. Ērlihioz 3. 16. Pertussis 2. 17. Gonococcal Infections (gonorrhea) 18 3. Hantavīrus infection 2. 19. proposed sexually transmitted chlamydial diseases, including Chlamydia Venereum (lymphogranulom-venere) 20 3. Cholera and cholera agent carrying 1. 21. Chronic viral hepatitis and hepatitis virus carrying 3.22. Invasive Haemophilus infuenza disease 3.23. Invasive meningococcal disease 2. 24. Invasive pneumococcal disease 3.25. Yersiniosis 2. 26. Campylobacter 2. 27. the Creutzfeldt-Jakob disease 3. 28. Cryptosporidiosis 2. 29. Lyme disease (laimborelioz) 3. 30. Legionnaires ' disease (legioneloz) 2. 31. the leprosy 3. 32. Leptospirosis 2. 33. Liesassērg (anthrax) * 1. 34. Listeriosis 2. 35. Malaria and the malaria agents carrying 3.36. Measles 2. 37. Rubella, congenital rubella, including indigenous rubella syndrome 2. 38. Meningitis, encephalitis 2. 39. Fever 1. 40. Ornithosis (psittacosis) 2. 41. Polio * 1. 42. The avian flu or other influenza, caused by a virus, which the World Health Organization considers the possible cause of the pandemic (until such time as will be found in influenza spreading sustainable) 1. 43. Q-fever 2. 44. West Nile fever 2. 45. they cause salmonellosis and carrying 2. 46. Syphilis, including congenital syphilis in newborn and 3. 47. the severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome (MER) * 1. 48. Tetanus (per) 2. 49. Shiga toxin produced by the Escerichi of the verotoksīn/coli infection (STEC/VTEC), haemolytic or trombocitār, urēmisk syndrome, haemorrhagic Purple 2. 50. and their agents carrying Shigellosis 2. 51. Toxoplasmosis (congenital) 3.52. Rabies 1. 53. Trichinosis 2. 54. Tuberculosis 3. 55. Tularemia 2. 56. So atguļ of fever of the 1. typhoid and paratyphoid fever 57., including typhoid and paratyphoid germs over 2. 58. Chicken pox 3. 59. Viral (rotavirus, a programme identifying norovirus, adenovīrus, astrovīrus, sapovīrus), intestinal infectious 3.60. Viral haemorrhagic fevers, including Ebola vīrusslimīb, Lassa fever, Marburg, vīrusslimīb of Crimean Congo haemorrhagic fever 1. 61. Žiardiāz 2.
The notes. 1.-dangerous infectious diseases. 2.-medical person reported one time on cases, approved pursuant to the provisions of annex 3. 3. the Cabinet of Ministers of 5 January 1999, regulations No 7 predetermines laboratory findings infectious pathogens, detection methods and target samples No. p. k. Agent of infectious disease (infectious disease) method the clinical material group i. bacterial infectious diseases 1. Bacillus anthrac (liesassērg, anthrax) isolation is not defined in the 1. nucleic acid detection is defined ** 1. 2. Bordetella pertussis (whooping cough) isolation is not defined * 2. nucleic acid detection is defined ** 2. specific antibody response in serum * 2. 3. Brucella spp. (brucellosis) isolation is not defined * 2. specific antibody response in serum * 2. 4. Campylobacter spp. (Campylobacter) isolation of faeces, blood 2. 5. Chlamydia trachomatis (Chlamydia proposed a sexually transmitted disease, including lymphogranulom venere, the LGV) isolation from the anoģenitāl tract or conjunctiva 2. direct response is not defined imūnfluorescenc ** 2. nucleic acid detection is defined ** 2. LGV: isolation or nucleic acid detection with additional serovariant L1, L2 or L3 (genovariant) identified no ** 2. 6. Clostridium botulinum (botulism) isolation of stools (infant botulism), material from the wound (wound botulism) 2. Botulinum Toxins detection is defined ** 2. 7. Clostridium tetan (tetanus) isolation of the affected site of infection 2. tetanus toxin detection serum 2. Corynebacterium diphtheriae 8, Corynebacterium ulcerans, Corynebacterium pseudotuberculos (diphtheria and diphtheria agents carrying) diphtheria toxins produced by c., c. ulcerans, c. pseudotuberculosis * not defined * 2. 9. Coxiell-burnetii (Q fever) isolation is not defined * 2. nucleic acid detection is defined ** 2. specific antibody response (IgG or IgM phase II) serum is reported 10. Against the karbapenēm of the family Enterobacteriaceae resistant micro-organisms of karbapenemāž of resistance determination not defined * 2. 11. the Escherichia coli, Shiga toxin that produces/verotoksīn (STEC/VTEC) Shiga toxin (Stx) or stx2 gene for stx1v (s) containing the e. coli strain isolation not defined * 2. sorbitol non fermentējoš (NSF) e. coli O157 isolate (no Stx and stx gene testing) 2 is not defined. stx1 or stx2 gene (s) direct detection of the nucleic acid (without strain isolation) * not defined * 2. free Stx direct detection (without strain isolation) stools 2. serogroups specific antibody response (LP) the serum only haemolytic urēmisk syndrome in case 2. identification (serotype, phage type, gene stx1 res or stx2 subtype characterization) * not defined * 2. 12. Francisella tularensis (tularemia) isolation is not defined * 2. nucleic acid detection is defined ** 2. specific antibody response in serum * 2. 13. Haemophilus influenza (invasive Haemophilus influenza a infection) usually sterile isolation material 2. the nucleic acid from a normally sterile material 2. 14. Legionell spp. (Legionnaires ' disease) isolation (Legionell spp.) respiratory secretions or other normally sterile material 2. nucleic acid detection (Legionell spp.) respiratory secretion, lung tissue or other normally sterile material 2. Antigen (the pneumophil Legionell) urine, respiratory secretions, lung tissue 2. specific antibody response against the serogrup of the pneumophil Legionell 1 (significant increase over single high Sera or serum titre) serum 2. specific antibody response against Legionell spp. 1. the serogrup or the pneumophil pair of Legionell Sera 2. 15. Leptospira spp. (leptospirosis) isolation is not defined * 2. nucleic acid detection is defined ** 2. determination method of imūnfluorescenc not defined * 2. specific antibody response in serum * 2. 16. the Listeria monocytogenes (listeriosis) normally sterile isolation material 2. isolation of non-sterile material, usually taken from the fruit, the stillborn baby, newborn baby or mother during delivery or within 24 hours after those 2. 17. the isseri Not gonorrhoea (gonococcal infection) is not defined in isolation. nucleic acid detection is defined ** 2. determination of nucleic acid probe without amplificēšan * not defined * 2. gramnegatīv of intracellular diplococci (gonococcal) smear from the male urethra 2. 18. do not isseri the detection of n. meningitidis (meningococcal invasive disease) usually sterile isolation material, purple skin damage 2. the nucleic acid from a normally sterile material, purple skin damage 2. Antigen likvor 2. of diplococci likvor gramnegatīv 2. 19. Salmonella spp., with the exception of title I of annex 3 paragraph 20 contains (salmonellosis and the agents carrying) isolate, faeces, urine, body (for example, infected wound) material, normally sterile body fluids and tissues (blood, bone, likvor, synovial fluid) 2. 20. Salmonella Typhi and salmonella paratyphii (typhoid and paratyphoid fever, typhoid and paratyphoid fever including agents carrying) isolation is not defined * 2. 21. Shigella spp. (and its agents carrying shigellosis) isolation is not defined * 2. 22. Streptococcus pneumoniae (invasive pneumococcal disease) usually sterile isolation material 2. the nucleic acid from a normally sterile material 2. Antigen from normally sterile material 2. the Treponema pallidum 23 (syphilis) dark field microscopy of exudate damage tissue, and the newborn congenital syphilis in the case of the umbilical cord, the placenta also, nasal secretions, skin material 2. direct response imūnfluorescenc to damage tissue, exudate, and the newborn congenital syphilis – also in the case of the umbilical cord, the placenta, the nasal discharge 2. nucleic acid detection (PCR) of exudate or tissue damage 2. screening test *** do not treponēmāl tests (VDRL, RPR SED) blood, serum is not reported ** ** ** * screening test – test (VDRL) treponēmāl baby likvor 2. screening test ***-demonstration of Treponema pallidum haemagglutination test (TPH) blood, serum is not reported ** ** ** * screening test-syphilis Express (quick syphilis tests) blood, serum, plasma does not have to notify the screening test ***-demonstration of Treponema pallidum particle agglutination test (tmp) blood, serum is not reported **** IgM and/or IgG specific antibodies (confirmation test), blood serum 2. 24. Vibrio cholerae (cholera) isolation is not defined in the 1. O1 or O139 Antigen from Vibrio cholerae isolates 1. Staphylococcal enterotoxins or gene of Vibrio cholerae isolates determinations 1. 25. Yersinia enterocolitica and Yersinia pseudotuberculos (yersiniosis) isolation is not defined * 2. 26. Yersinia pestis (plague) isolation is not defined in the 1. nucleic acid detection (F1 Antigen) is not defined in the 1. specific antibody response (against Yersinia pestis F1 Antigen) serum 1. II. Viral infectious diseases 1. Hepatitis a virus (hepatitis A) nucleic acid detection serum, stools 2. specific antibody response in serum 2. Antigen stool 2. 2. Hepatitis B virus (hepatitis B) IgM antibody to hepatitis B virus core Antigen (anti-HBc IgM) serum 2. surface antigen (HBsAg) serum 2. e Antigen (HBeAg) serum 2. nucleic acid detection (HBV-DNA) serum 2. 3. Hepatitis C virus (hepatitis C) nucleic acid detection (HCV-RNA) serum 2. the virus core Antigen (HCV-core) serum 2. specific antibody (anti-HCV) response, which was approved by the affirmative determination of antibody (e.g. imūnblot) test persons over 18 months, with no evidence of infection in serum 2 cured. 4. Dengue fever (dengue fever) virus isolation is not defined * 2. nucleic acid detection is defined ** 2. Antigen is not defined * 2. specific antibody response in serum * 2. 5. Yellow fever virus (yellow fever) isolation is not defined * 2. nucleic acid detection is defined ** 2. Antigen is not defined * 2. specific antibody response in serum * 2. histology section (liver) 2. 6. Involved (meningitis, encephalitis) isolation and tipēšan is not defined. specific antibody response in serum do not have to report the nucleic acid detection is defined ** 2. 7. the epidemic mumps virus (mumps) isolation is not defined * 2. nucleic acid detection is defined ** 2. specific antibody response characteristic for acute infection, serum, saliva for 2. 8. Lyss virus (rabies) isolation is not defined * 2. nucleic acid detection is defined ** 2. virus Antigen detection (direct response imūnfluorescenc) * not defined * 2. specific antibody response to the virus neutralisation test for serum, likvor 2. 9. Rubella virus (rubella) isolation is not defined * 2. nucleic acid detection is defined ** 2. specific antibody response (IgG), serum, saliva 2. specific antibody response (IgM) * not defined * 2. 10. Measles (measles) virus isolation is not defined * 2. nucleic acid detection is defined ** 2. specific antibody response characteristic for acute infection, serum, saliva for 2. direct imūnfluorescenc reaction with monoclonal antibodies ** not defined 2. 11. Polio virus (polio or acute flaccid paralysis) isolation and tipēšan is not defined in the 1. 12. Avian influenza a virus (A/H5 or A/H5N1) or other influenza virus, which the World Health Organisation of a possible pandemic recognised agent virus isolation is not defined in the 1. nucleic acid detection is defined ** 1. specific antibody response (fourfold or greater increase in titre or single high titre) serum 1. 13. West Nile fever virus (West Nile fever) isolation of blood, likvor 2. nucleic acid detection in the blood, likvor 2. specific IgM antibody response likvor 2. high IgM and IgG antibody titre determination and validation of antibodies with serum neutralization 2. specific antibody response in serum 2. 14. SARA-coronavir (severe acute respiratory syndrome (SARS, SARS-coV)) the isolation and identification of RT-PCR using a method not defined * 1. SARS-coV nucleic acid detection by RT-PCR method has not been defined in the 1. SARS-coV antibody serum 1. 15. The Middle East koronavīrus respiratory syndrome (MER-coV) MERs-coV detection with PCR * not defined * 1. MER-coV detection of serological serum 1. 16. Variol (smallpox) virus isolation and sequence determination not defined * 1. nucleic acid detection and sequence determination not defined * 1. Orthopox virus particle identification with electron microscopy (EM) is not defined in the 1. 17. the viruses that cause intestinal infections (programme identifying norovirus, rotavirus, adenovīrus, astrovīrus, sapovīrus) Antigen Discovery 2 stools. nucleic acid detection stools 2. 18. viruses causing viral hemorāģisko in fever (viral haemorrhagic fevers) isolation is not defined in the 1. nucleic acid detection and genotyping ** not defined 1. III. Parasitic infectious diseases 1. Cryptosporid (Cryptosporidiosis) determination of Oocyst stools 2. determination of intestinal parasites, small intestine biopsy material 2. nucleic acid detection stools 2. Antigen stool 2. 2. Echinococcus spp. (echinococcosis) specific antibody response in serum * 2. nucleic acid detection is defined ** 2. macroscopic or microscopic, histological detection is defined ** 2. 3. the lambli Compatible (žiardiāz) cyst or determination of trofozoīt, duodenāl liquid stools, small intestine biopsy material 2. Antigen stool 2. 4. Plasmodi spp.. (malaria) parasites detection using light microscopy smear of blood 2. nucleic acid detection blood 2. Antigen is not defined * 2. Plasmodi spp.. differentiation is not defined * 2. 5. the Toxoplasm manmad (congenital toxoplasmosis) detection of t.gondii body tissue or fluids 2. nucleic acid detection is defined ** 2. specific antibody response (IgM, IgG, IGA) newborn serum 2. IgG titre in the infant up to the age of 12 months * not defined * 2. 6. the Trichinella spp. (trichinosis) Trichinella larvae in muscle biopsy for detection of tissue 2. specific antibody response in serum 2.
The notes. 1. the specific antibody response – unless otherwise indicated – IgM antibody presence if the patient recently, there has been no vaccination or diagnostically important specific antibody titre. 2. ** not defined – clinical material is determined by the type of treatment a person according to the progress of the disease and laboratory requirements for sample collection procedures and testing methods. 3. Screening test ***-if diagnosed with syphilis, screening test by specific IgM and IgG class antibodies, or test-imūnfermentatīv test imūnblot test imūnfluorescenc test (FTA-ABS). 4. No reporting **** – except when laboratory tests positive result found the newborn's mother or child up to two years of age. " 13. Replace the title of the annex, the word "case" with the words "Acinetobacter spp./Acinetobacter micro-organisms" baumanni. 14. Complement 4. part II of the annex to table 7 as follows: "Acinetobacter baumanni/Acinetobacter 7 spp., isolated from the blood, likvor, or other normally sterile clinical material No. p. k. Antimicrobial means definitive interpretation (S, I, R, or NI) disc method (mm) disc method of interpretation (S, I, R, or NI) MIC (mg/l) MIC interpretation (S, I, R, or NI) E-test (mg/l) E-test interpretation (S, I, R, or NI) 1. Ciprofloxacin and/or levofloksacīn 2. Gentamicin and/or tobramicīn 3. Imipenēm and/or meropenēm and/or doripenēm 4. Colistin 5. Amikacīn other methods of testing: Karbapenemāz: positive negative unknown. "
The Prime Minister is the Minister of Health Newsletters Speed site-economic Minister Dana Reizniec-oak